PlainPatent
USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Hanall Biopharma Co., Ltd.

USPTO PatentsView assignee record - 9 granted patents across 7 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

RSS updates for this company
Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Hanall ranks #28,923 of 49,997 tracked US assignees by granted-patent volume, with 9 patents across 7 technology areas.

#28,923
of 49,997 US assignees by volume
30th percentile
by Innovation Score (29.1/100)
12.3
avg claims per patent
-50%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R28923 · Foreign Corporation #28,923 · 9 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

  • GRANTS-MICRO 9 grants
  • MID-PACK #28,923/49,997
  • PHOTO-FINISH Halo Trademarks
  • CPC-NARROW A61K · 7 areas
  • INNOV-THIN 29.1/100
  • CLAIMS-RICH 12.3 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-DROP -50% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Halo Trademarks Limited (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Hanall’s 29.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Hanall

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Hanall's Innovation Score is 29.1/100 (30th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Hanall?

Each dot is one of Hanall’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Hanall’s own 12.3 claims/patent is ABOVE the 9.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Hanall vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 8.98.999.1 051015 Granted patents (volume) Avg claims / patent Halo Trademarks Limited - 9, 1Halo TrademarksHampton University - 9, 12.67Hampton UniversityHan's CNC Science AND Technology Co., Ltd - 9, 11Han's CNC Science…Hana Micron Inc. - 9, 9.67Hana MicronHandy Button Machine Co. - 9, 7.11Handy Button Mach…Hangzhou Hikrobot Co., Ltd. - 9, 11.67Hangzhou HikrobotHangzhou Mo-link Technology Co. Ltd - 9, 10.22Hangzhou Mo-link…Hanmi IT Co., Ltd. - 9, 6Hanmi ITHanall Biopharma Co., Ltd. - 9, 12.33Hanall Biopharma
Hanall vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Hanall's grants concentrate

Hanall Biopharma Co., Ltd. is a focused PatentsView assignee: 7 CPC subclasses with 88.9% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2015 (2 grants) versus a trough of 1 in 2020. By volume, Hanall sits between Halo Trademarks Limited and Hanmi IT Co., Ltd..

Hanall's three-year grant acceleration

Hanall Biopharma Co., Ltd. shows 2 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Hanall's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Hanall holds 9 patents at rank #28,911, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Hanall

By rank, the assignees closest to #28,911 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Hanall's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Hanall, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), Hanall ranks #2,696 of 7,163 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (29 here).

Aeroprobe Corporation 29 Agile Therapeutics, Inc. 29 LTT Bio-Pharma Co., Ltd. 29 Anchorfree Inc. 29

Hanall's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

29 30th percentile higher than 30% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.5 201520172019202020232024 1
USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Hanall Biopharma Co., Ltd. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 2 22.2%
2017 2 22.2%
2019 2 22.2%
2020 1 11.1%
2023 1 11.1%
2024 1 11.1%

Which technologies does Hanall Biopharma Co., Ltd. patent most?

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Hanall Biopharma Co., Ltd.'s patent record in context - here's where to go next.

  • Hanall Biopharma Co., Ltd.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 88.9% of its portfolio - see every assignee active in that class. Explore A61K
  • Ranked #28,923 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Hanall Biopharma Co., Ltd. against Halo Trademarks Limited, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 29.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page
  • USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.